Peter Olofsson Selected Research

neutrophil cytosolic factor 1

1/2012	Copy number variation of the gene NCF1 is associated with rheumatoid arthritis.
5/2007	Arthritis suppression by NADPH activation operates through an interferon-beta pathway.
8/2006	T cell surface redox levels determine T cell reactivity and arthritis susceptibility.
1/2003	Positional identification of Ncf1 as a gene that regulates arthritis severity in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Olofsson Research Topics

Disease

24	Arthritis (Polyarthritis) 01/2020 - 01/2002
10	Inflammation (Inflammations) 01/2021 - 01/2002
10	Rheumatoid Arthritis 01/2016 - 08/2002
5	Experimental Arthritis 01/2016 - 08/2003
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2017 - 01/2013
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 08/2004 - 01/2003
2	Multiple Sclerosis 08/2004 - 01/2003
1	Acute Disease 01/2020
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Animal Disease Models 01/2019
1	Neuroinflammatory Diseases 11/2017
1	Glomerulonephritis 05/2017
1	Weight Loss (Weight Reduction) 01/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2014
1	Chronic Granulomatous Disease 12/2014
1	Reinfection 12/2014
1	Kidney Diseases (Kidney Disease) 12/2014
1	Encephalomyelitis (Myeloencephalitis) 04/2009
1	Bronchitis 09/2008
1	Autoimmune Diseases (Autoimmune Disease) 10/2007
1	Necrosis 09/2006
1	Lyme Disease (Disease, Lyme) 09/2005
1	Hypersensitivity (Allergy) 08/2004
1	Acute-Phase Reaction 01/2002

Drug/Important Bio-Agent (IBA)

16	pristane (pristan)IBA 01/2020 - 01/2002
8	NADPH Oxidases (NAD(P)H oxidase)IBA 11/2017 - 01/2003
7	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2017 - 09/2005
5	Proteins (Proteins, Gene)FDA Link 11/2017 - 12/2003
4	Immunoglobulin G (IgG)IBA 12/2014 - 12/2003
4	neutrophil cytosolic factor 1IBA 01/2012 - 01/2003
3	Pharmaceutical PreparationsIBA 01/2021 - 11/2017
3	EnzymesIBA 11/2017 - 01/2012
2	Biological ProductsIBA 01/2018 - 09/2006
2	CytokinesIBA 01/2018 - 01/2017
2	Immunomodulating AgentsIBA 01/2018 - 01/2017
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2016 - 01/2002
2	Rheumatoid FactorIBA 09/2008 - 12/2003
2	PhytolIBA 05/2007 - 09/2006
2	NADP (NADPH)IBA 05/2007 - 09/2005
2	Glycoproteins (Glycoprotein)IBA 01/2007 - 01/2002
2	Myelin-Oligodendrocyte GlycoproteinIBA 08/2004 - 01/2003
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2019
1	LigandsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 11/2017
1	Protein Isoforms (Isoforms)IBA 11/2017
1	LipidsIBA 11/2017
1	Nucleic AcidsIBA 11/2017
1	Antinuclear AntibodiesIBA 05/2017
1	arginine deiminaseIBA 05/2017
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2016
1	Etanercept (Enbrel)FDA Link 01/2016
1	Prion ProteinsIBA 01/2013
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2012
1	Superoxide DismutaseIBA 01/2012
1	Superoxides (Superoxide)IBA 01/2012
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 06/2011
1	NucleotidesIBA 06/2011
1	Therapeutic UsesIBA 04/2009
1	OvalbuminIBA 09/2008
1	AutoantibodiesIBA 09/2008
1	Immunoglobulin E (IgE)IBA 09/2008
1	Interferon-betaIBA 05/2007
1	AcidsIBA 01/2007
1	Methotrexate (Mexate)FDA LinkGeneric 09/2006
1	Glutathione (Reduced Glutathione)IBA 08/2006
1	Sulfhydryl Compounds (Thiols)IBA 08/2006
1	Histocompatibility Antigens Class IIIBA 01/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2006
1	Oxidoreductases (Dehydrogenase)IBA 09/2005
1	Collagen Type II (Type II Collagen)IBA 08/2004
1	Cartilage Oligomeric Matrix ProteinIBA 12/2003
1	Immunoglobulins (Immunoglobulin)IBA 12/2003
1	Immunoglobulin M (IgM)IBA 12/2003
1	Fibrinogen (Factor I)FDA Link 01/2002
1	Interleukin-6 (Interleukin 6)IBA 01/2002
1	Orosomucoid (Seromucoid)IBA 01/2002

Therapy/Procedure

3	Therapeutics 01/2021 - 09/2006
1	Thymectomy 01/2020
1	Subcutaneous Injections 01/2007